Medexus Pharmaceuticals (MDP) Stock Chart & Stock Price History C$2.66 -0.08 (-2.92%) As of 08/1/2025 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Medexus Pharmaceuticals Stock Price Performance The Medexus Pharmaceuticals (MDP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 16.67%, with a year-to-date return of -23.12%. In the past month, the stock has decreased 15.02%, reflecting recent market activity. As of the latest close, Medexus Pharmaceuticals traded at C$2.66 with a market cap of C$59.55 million and volume of 39,716 shares. Receive MDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.32%1 Month Performance-15.02%3 Month Performance-3.62%Year-To-Date Performance-23.12%1 Year Performance+16.67% MDP Stock Chart for Saturday, August, 2, 2025 MDP Chart by TradingView Medexus Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025C$2.74C$2.66-2.92%C$2.75C$2.6539,716 shsC$59.55 million07/31/2025C$2.79C$2.74-1.79%C$2.77C$2.7327,920 shsC$61.34 million07/30/2025C$2.80C$2.79-0.36%C$2.84C$2.7913,941 shsC$62.46 million07/29/2025C$2.87C$2.80-2.44%C$2.88C$2.8035,264 shsC$62.69 million07/28/2025C$2.84C$2.87+1.06%C$3.02C$2.7717,178 shsC$64.25 million07/25/2025C$2.78C$2.84+2.16%C$2.87C$2.7231,526 shsC$63.58 million07/24/2025C$2.70C$2.78+2.96%C$2.79C$2.6819,586 shsC$62.24 million07/23/2025C$2.65C$2.70+1.89%C$2.72C$2.6120,360 shsC$60.45 million07/22/2025C$2.74C$2.65-3.28%C$2.75C$2.6528,572 shsC$59.33 million07/21/2025C$2.81C$2.74-2.49%C$2.84C$2.7147,958 shsC$61.34 million Get the Latest News and Ratings for MDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025C$2.88C$2.81-2.43%C$2.90C$2.8126,097 shsC$62.91 million07/17/2025C$2.82C$2.88+2.13%C$2.92C$2.8337,072 shsC$64.48 million07/16/2025C$2.80C$2.82+0.71%C$2.85C$2.7844,920 shsC$63.14 million07/15/2025C$2.94C$2.80-4.76%C$2.93C$2.8028,312 shsC$62.69 million07/14/2025C$2.93C$2.94+0.34%C$2.97C$2.8850,075 shsC$65.82 million07/11/2025C$3.06C$2.93-4.25%C$3.12C$2.8924,029 shsC$65.60 million07/10/2025C$2.96C$3.06+3.38%C$3.08C$3.0037,344 shsC$68.51 million07/09/2025C$3.01C$2.96-1.66%C$3.05C$2.9631,891 shsC$66.27 million07/08/2025C$3.01C$3.01C$3.10C$3.0119,200 shsC$67.39 million07/07/2025C$3.11C$3.01-3.22%C$3.14C$3.0155,966 shsC$67.39 million07/04/2025C$3.03C$3.11+2.64%C$3.12C$2.9832,516 shsC$69.63 million07/03/2025C$3.13C$3.03-3.19%C$3.18C$3.0245,855 shsC$67.84 million07/02/2025C$3.17C$3.13-1.26%C$3.29C$3.1337,144 shsC$70.08 million07/01/2025C$3.17C$3.17C$3.24C$3.1514,211 shsC$70.97 million Related Companies Cipher Pharmaceuticals Stock Chart Cardiol Therapeutics Stock Chart BioSyent Stock Chart HLS Therapeutics Stock Chart SugarBud Craft Growers Stock Chart Decibel Cannabis Stock Chart Willow Biosciences Stock Chart Voyageur Pharmaceuticals Stock Chart MediPharm Labs Stock Chart Charlotte's Web Stock Chart Receive MDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:MDP) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
